These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Symptomatic treatment of chronic cardiac insufficiency]. Zannad F Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1927-34. PubMed ID: 2125411 [TBL] [Abstract][Full Text] [Related]
44. [Therapy of heart failure. Digitalis, diuretic plus ACE inhibitor or more?]. Becker H; Sigmund M Internist (Berl); 1995 Dec; 36(12):1117-23. PubMed ID: 8567216 [No Abstract] [Full Text] [Related]
45. Medical treatment of end-stage heart failure. Binetti G; Senni M; Colombo F; Tasca G; Mamprin F; Caporale R; Ferrazzi P; Gamba A; Glauber M; Troise G; Fiocchi R Cardiovasc Drugs Ther; 1996 Nov; 10 Suppl 2():617-22. PubMed ID: 9115955 [TBL] [Abstract][Full Text] [Related]
46. [Pharmacotherapy of chronic heart failure in clinical practice]. Halawa B Pol Merkur Lekarski; 2004 Apr; 16(94):307-12. PubMed ID: 15517921 [TBL] [Abstract][Full Text] [Related]
47. [Observations on the management of cardiac failure in ambulatory patients. Results of a survey of cardiologists]. Komajda M; Bouhour JB; Amouyel P; Delahaye F; Vicaut E; Croce I; Rougemond E; Vuittenez F; Leutenegger E Arch Mal Coeur Vaiss; 2001 Apr; 94(4):257-61. PubMed ID: 11387930 [TBL] [Abstract][Full Text] [Related]
48. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D; Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942 [TBL] [Abstract][Full Text] [Related]
49. [Pharmacologic interactions with nitrates in patients with, or at risk of, cardiac decompensation]. Filardi PP; Chiariello M G Ital Cardiol; 1996 Sep; 26(9):1085-8. PubMed ID: 9036050 [No Abstract] [Full Text] [Related]
50. [Treatment of refractory cardiac insufficiency by peritoneal ultrafiltration. Literature review]. Lécluse E; Ryckelink JP; Lobbedez T; Saloux E; Duarte C; Devaluez F; Hurault de Ligny BH; Valette B; Hamon M; Grollier G; Potier JC Ann Cardiol Angeiol (Paris); 1999 Jan; 48(1):32-6. PubMed ID: 12555356 [TBL] [Abstract][Full Text] [Related]
51. [Treatment of dilated cardiomyopathies. Recent findings]. Perret C Ann Cardiol Angeiol (Paris); 1986 Jun; 35(6):311-6. PubMed ID: 2877610 [TBL] [Abstract][Full Text] [Related]
52. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables. Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580 [TBL] [Abstract][Full Text] [Related]
56. [Management of heart failure by French general practitioners in 2003]. Jondeau G; Allaert FA; Leurs I Arch Mal Coeur Vaiss; 2004 Sep; 97(9):833-9. PubMed ID: 15521474 [TBL] [Abstract][Full Text] [Related]
57. [Vasodilator agents in chronic heart failure: which is the best option?]. Corbalán R; Kunstmann S; Jalil J Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172 [TBL] [Abstract][Full Text] [Related]
58. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII]. Dessì-Fulgheri P; Paci MV; Rappelli A Ann Ital Med Int; 1994 Oct; 9 Suppl():16S-18S. PubMed ID: 7857751 [TBL] [Abstract][Full Text] [Related]
59. Digitalis in patients after myocardial infarction. Mølstad P Herz; 1993 Apr; 18(2):118-23. PubMed ID: 8491440 [TBL] [Abstract][Full Text] [Related]
60. [Actual and theoretical points of view in the application of coronary therapeutic agents]. Döring D Z Gesamte Inn Med; 1980 Jun; 35(11):475-81. PubMed ID: 6108022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]